newsfilter
← Latest News
GlobeNewswire·

Homology Medicines Reports First Quarter 2023 Financial Results and Recent Highlights

- On Track to Report Initial Clinical Data from pheEDIT PKU Gene Editing Trial Mid-Year 2023 - - First Presentations of Preclinical Data with GTx-mAb Development Candidate HMI-104 for PNH, and Potential for Re-Dosing